CTRI/2010/091/001055已完成3 期
A randomized, open label, comparative, multicentric study to assess the efficacy and safety of Revaprazan tablets in comparison with Omeprazole capsules in patients suffering from Peptic Ulcer or Acute Gastritis
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of either sex of 19 to 75 years of age.
- •2.Established diagnosis of peptic ulcer or acute gastritis.
- •3.Informed consent of the patient/relative.
排除标准
- •1.Pregnancy or Lactation.
- •2.Clinically significant disorder of liver, kidney, cardiovascular system, respiratory system, endocrine system and CNS.
- •3.Not eligible to undergo endoscopy.
- •4.Zollinger-Ellison syndrome.
- •5.Patients requiring use of any unacceptable concomitant medications
- •6.Patients with any other serious concurrent illness or malignancy.
- •7.Patients with continuing history of alcohol and / or drug abuse.
- •8.Participation in another clinical trial in the past 3 months.
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of two drugs, fixed dose combination capsules of Celecoxib and Diacerein and fixed dose combination tablets of Aceclofenac and Diacerein in patients with osteoarthritis of knee and/or hip joints.CTRI/2010/091/000053Cadila Healthcare Ltd200
已完成
3 期
A clinical trial to study effectiveness and safety of Fixed dose combination tablets of Hyoscine butylbromide & Mefenamic acid in patients suffering from paroxysmal spastic abdominal paiCTRI/2011/091/000141Cadila Healthcare Ltd200
已完成
3 期
A clinical trial to study effectiveness and safety of Acrivastine capsules in comparison with Chlorpheniramine maleate tablets in patients suffering from allergic rhinitisCTRI/2010/091/001368Cadila Healthcare Ltd200
已完成
3 期
A clinical trial to study to assess effectiveness and safety of two medications for the treatment for schizophreniaCTRI/2011/091/000140Cadila Healthcare Ltd200
Unknown
4 期
To determine the efficacy and safety of a combination of Extended Release (ER) Niacin and Rosuvastatin as compared with Rosuvastatin alone in patients with Mixed Dyslipidemia.CTRI/2010/091/003016Troikaa Pharmaceuticals Ltd160